|
TMED7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.46149997343792E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.6008000197919E-09 |
| Normal-vs-Stage2 |
2.404000E-03 |
| Normal-vs-Stage3 |
4.474000E-02 |
| Normal-vs-Stage4 |
2.730200E-01 |
| Stage1-vs-Stage2 |
4.856800E-01 |
| Stage1-vs-Stage3 |
6.173600E-02 |
| Stage1-vs-Stage4 |
1.800400E-01 |
| Stage2-vs-Stage3 |
4.159400E-01 |
| Stage2-vs-Stage4 |
4.554000E-01 |
| Stage3-vs-Stage4 |
9.191200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.06829994745073E-09 |
| Normal-vs-AfricanAmerican |
1.58246999999445E-05 |
| Normal-vs-Asian |
7.083600E-01 |
| Caucasian-vs-AfricanAmerican |
5.778400E-01 |
| Caucasian-vs-Asian |
1.757550E-01 |
| AfricanAmerican-vs-Asian |
2.548800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.38989947223922E-10 |
| Normal-vs-Female |
3.476600E-03 |
| Male-vs-Female |
3.001800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.93590000000721E-05 |
| Normal-vs-Extreme_Weight |
1.32349997628012E-09 |
| Normal-vs-Obese |
2.37690000000068E-05 |
| Normal-vs-Extreme_Obese |
1.618710E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.298800E-01 |
| Normal_Weight-vs-Obese |
6.517800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.940200E-01 |
| Extreme_Weight-vs-Obese |
1.512380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.822000E-01 |
| Obese-vs-Extreme_Obese |
4.947200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.919790E-03 |
| Normal-vs-Age(41-60Yrs) |
1.90972999999373E-05 |
| Normal-vs-Age(61-80Yrs) |
3.30030003325987E-10 |
| Normal-vs-Age(81-100Yrs) |
9.5884000000046E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.596000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.283800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.873400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.645800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.857000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.485600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.00589980789323E-10 |
| Normal-VS-Type2 PRCC |
6.616600E-04 |
| Normal-VS-KIRP CIMP |
6.023100E-04 |
| Normal-VS-Unclassified PRCC |
9.281200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.562500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.228600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.716200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.956200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.532800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.962000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.82050000000689E-05 |
| Normal-vs-N1 |
6.385700E-02 |
| Normal-vs-N2 |
1.213410E-01 |
| N0-vs-N1 |
2.573600E-01 |
| N0-vs-N2 |
6.138200E-01 |
| N1-vs-N2 |
9.615800E-01 |
|
|
